Tomita DK - Search Results

1

Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks.

Gabrilove JL, Perez EA, Tomita DK, Rossi G, Cleeland CS. Gabrilove JL, et al. Among authors: tomita dk. Cancer. 2007 Oct 1;110(7):1629-40. doi: 10.1002/cncr.22943. Cancer. 2007. PMID: 17694552 Free article. Clinical Trial.

2

Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes.

Gabrilove J, Paquette R, Lyons RM, Mushtaq C, Sekeres MA, Tomita D, Dreiling L. Gabrilove J, et al. Br J Haematol. 2008 Jul;142(3):379-93. doi: 10.1111/j.1365-2141.2008.07181.x. Epub 2008 Jun 6. Br J Haematol. 2008. PMID: 18540943 Free PMC article. Clinical Trial.

3

Darbepoetin alfa in lung cancer patients on chemotherapy: a retrospective comparison of outcomes in patients with mild versus moderate-to-severe anaemia at baseline.

Vansteenkiste J, Tomita D, Rossi G, Pirker R. Vansteenkiste J, et al. Support Care Cancer. 2004 Apr;12(4):253-62. doi: 10.1007/s00520-003-0583-0. Epub 2004 Jan 23. Support Care Cancer. 2004. PMID: 14740283 Clinical Trial.

4

A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia.

Schwartzberg L, Shiffman R, Tomita D, Stolshek B, Rossi G, Adamson R. Schwartzberg L, et al. Clin Ther. 2003 Nov;25(11):2781-96. doi: 10.1016/s0149-2918(03)80333-8. Clin Ther. 2003. PMID: 14693304

5

Treatment of chemotherapy-induced anemia in breast cancer: results of a randomized controlled trial of darbepoetin alfa 200 microg every 2 weeks versus epoetin alfa 40,000 U weekly.

Senecal FM, Yee L, Gabrail N, Charu V, Tomita D, Rossi G, Schwartzberg L. Senecal FM, et al. Clin Breast Cancer. 2005 Dec;6(5):446-54. doi: 10.3816/cbc.2005.n.050. Clin Breast Cancer. 2005. PMID: 16381629 Clinical Trial.

6

Efficacy and safety of every-2-week darbepoetin alfa in patients with anemia of cancer: a controlled, randomized, open-label phase II trial.

Charu V, Belani CP, Gill AN, Bhatt M, Tomita D, Rossi G, Ben-Jacob A. Charu V, et al. Oncologist. 2007 Jun;12(6):727-37. doi: 10.1634/theoncologist.12-6-727. Oncologist. 2007. PMID: 17602062 Free article. Clinical Trial.

7

A randomized, open-label, multicenter trial of immediate versus delayed intervention with darbepoetin alfa for chemotherapy-induced anemia.

Charu V, Saidman B, Ben-Jacob A, Justice GR, Maniam AS, Tomita D, Rossi G, Rearden T, Glaspy J. Charu V, et al. Oncologist. 2007 Oct;12(10):1253-63. doi: 10.1634/theoncologist.12-10-1253. Oncologist. 2007. PMID: 17962619 Free article. Clinical Trial.

8

A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer.

Schwartzberg LS, Yee LK, Senecal FM, Charu V, Tomita D, Wallace J, Rossi G. Schwartzberg LS, et al. Oncologist. 2004;9(6):696-707. doi: 10.1634/theoncologist.9-6-696. Oncologist. 2004. PMID: 15561813 Free article. Clinical Trial.

9

Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: the 20030125 Study Group Trial.

20030125 Study Group Trial; Glaspy J, Vadhan-Raj S, Patel R, Bosserman L, Hu E, Lloyd RE, Boccia RV, Tomita D, Rossi G. 20030125 Study Group Trial, et al. J Clin Oncol. 2006 May 20;24(15):2290-7. doi: 10.1200/JCO.2005.03.8570. J Clin Oncol. 2006. PMID: 16710026 Clinical Trial.

10

A Randomized, Double-Blind, Placebo-Controlled, Phase III Noninferiority Study of the Long-Term Safety and Efficacy of Darbepoetin Alfa for Chemotherapy-Induced Anemia in Patients With Advanced NSCLC.

Gascón P, Nagarkar R, Šmakal M, Syrigos KN, Barrios CH, Sánchez JC, Zhang L, Henry DH, Gordon D, Hirsh V, Kubota K, Orlov S, Thomas G, Steinmetz T, Kang JH, Tomita DK, Fleishman AN, Park JK, De Oliveira Brandao C. Gascón P, et al. Among authors: tomita dk. J Thorac Oncol. 2020 Feb;15(2):190-202. doi: 10.1016/j.jtho.2019.10.005. Epub 2019 Oct 16. J Thorac Oncol. 2020. PMID: 31629060 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters